The use of skeletal muscle relaxants in musculoskeletal injuries: what is the evidence?

  title={The use of skeletal muscle relaxants in musculoskeletal injuries: what is the evidence?},
  author={Dina Janse van Rensburg and Audrey Jansen van Rensburg and Gehart Kalmeier and Carel T. Viljoen and Dimakatso A Ramagole and Martin P. Schwellnus},
  journal={South African Family Practice},
Skeletal muscle relaxants (SMRs) consist of a heterogeneous group of medications with a side effect profile of concern. The aim of this paper was to review the evidence of use of SMRs in the treatment of sports injuries. A literature search between 2005 – 2018 (Ovid MEDLINE, SPORTDiscus and SCOPUS) were conducted. In addition, citations within articles were searched, and the most commonly prescribed SMRs in South Africa were also used to explore the literature for additional publications… 
1 Citations

Tables from this paper

Orphenadrine in treatment of muscle cramps in cirrhotic patients: a randomized study
Frequency, duration, and pain score improved significantly after 1 month of orphenadrine therapy in comparison to placebo, and is considered as promising safe drug for treatment of muscle cramps associated with liver cirrhosis.


A Clinical and Pharmacologic Review of Skeletal Muscle Relaxants for Musculoskeletal Conditions
Only a limited number of high-quality, randomized, controlled trials (RCTs) provide evidence of the effectiveness of NSAIDs or SMRs in the treatment of acute, uncomplicated MSDs, and remarkably little sound science guides the choice of drug.
Muscle Relaxants for Nonspecific Low Back Pain: A Systematic Review Within the Framework of the Cochrane Collaboration
There is strong evidence that any of these muscle relaxants are more effective than placebo for patients with acute low back pain on short-term pain relief, but the adverse effects require that they be used with caution.
1. The use of therapeutic medications for soft‐tissue injuries in sports medicine
The use of non-steroidal anti-inflammatory drugs (NSAIDs) to treat most muscle, ligament and tendon injuries should be reassessed and promising new therapeutic treatments for soft-tissue injuries include topical glyceryl trinitrate, aprotinin injections, and prolotherapy.
Evidence-based prescription for cyclo-oxygenase-2 inhibitors in sports injuries
Although the use of anti-inflammatory treatment in the form of a cyclo-oxygenase-2 inhibitor (coxibs) has been widely recognised as being effective, the potential detrimental effect on tissue repair, as described mainly in animal model studies, needs to be taken into account.
Medicinal and injection therapies for mechanical neck disorders.
In participants with chronic MND with or without radicular findings, epidural methylprednisolone and lidocaine reduced neck pain and improved function at one-year follow-up compared to the intramuscular route, and other treatments including NSAIDS and nerve blocks had unclear or limited evidence of benefit.
Treatment Options for Low Back Pain in Athletes
Superficial heat and spinal manipulation therapy are the most strongly supported evidence-based therapies in the initial management of low back pain; however, both have considerable side effects that must be considered.
Corticosteroids in sports-related injuries: Friend or Foe
It was found that, despite some controversy in the use of corticosteroid treatment in the sports environment, little empirical evidence exists that could conclusively rule for or against its use.
Pharmacological and Interventional Management of Pain After Whiplash Injury.
  • M. Curatolo
  • Medicine
    The Journal of orthopaedic and sports physical therapy
  • 2016
Synopsis Whiplash-associated disorder (WAD) is a group of symptoms and clinical manifestations resulting from rear-end or side impact. Despite the wide use of medications in WAD, the published
Critical Review of Prolotherapy for Osteoarthritis, Low Back Pain, and other Musculoskeletal Conditions: A Physiatric Perspective
The clinical efficacy of prolotherapy in treating osteoarthritis, low back pain, and other musculoskeletal conditions remains inconclusive.